Regeneron Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2025
Total Assets: $40.56B
Liabilities Breakdown FY2025
Total Liabilities: $9.30B
Asset Breakdown
Total Assets: $40.56B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.12B | 7.7% |
| Accounts Receivable | $5.74B | 14.2% |
| Inventory | $3.20B | 7.9% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $1.26B | 3.1% |
| Other Assets | $27.24B | 67.2% |
Liabilities Breakdown
Total Liabilities: $9.30B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $939.0M | 10.1% |
| Long-Term Debt | $1.99B | 21.3% |
| Other Liabilities | $6.38B | 68.6% |